Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-27

Clinical Trial Update: ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology [NA]

View source ↗

Summary

This clinical trial assessed aspirin and clopidogrel therapy with the WATCHMAN left atrial appendage closure device in patients with atrial fibrillation. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Plavix (clopidogrel)
  • WATCHMAN Left Atrial Appendage Closure Technology

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation | NA | Status: COMPLETED